_Market.JPG)
Vendor Neutral Archive (VNA) Market Size is valued at USD 3.85 Bn in 2023 and is predicted to reach USD 5.81 Bn by the year 2031 at a 5.48% CAGR during the forecast period for 2024-2031.
Vendor-Neutral Archive (VNA) is a platform for managing enterprise-wide images and storing patient-centric medical studies, photos, and other unstructured clinical content generated by care activities. Integrating with all major PACS and meeting the proprietary needs of vendors and healthcare providers for medical image storage, retrieval, manipulation, and display allows for vendor neutrality. VNA use is the continuous digitization of healthcare. Converting paper medical records into digital ones is considered crucial for improving the efficiency and accessibility of patient data. The digitization of medical imaging and diagnostic information is a part of this larger shift. Virtual nurse analytic systems (VNAs) are becoming more important for healthcare providers transitioning to digital health records. Furthermore, PACS, which stands for picture storage and transmission system, is expected to be surpassed by vendor-neutral archives in terms of vendor flexibility and accessibility, leading to a substantial expansion of the vendor-neutral archive industry.
However, the market growth is hampered by the high-cost criteria for the safety and health of the neutral archive (VNA) market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high vendor-neutral archive, because a large sum of money is usually needed to deploy a VNA system, which includes modifications to the IT infrastructure, operating system, and hardware. To add insult to injury, firms with limited resources may find it challenging to adopt due to the technical skill demands. The implementation issues and high cost of VNAs might be an important challenge, especially for smaller healthcare facilities. In addition, the COVID-19 pandemic has had significant effects on the market. Diagnostic centers, clinics, hospitals, and mobile clinics saw an uptick in patients with COVID-19 and an increase in the need for diagnostic tests throughout the pandemic. It increased the demand for VNA integration with hospital systems for faster diagnosis and easier access to patient records.
Competitive Landscape
Some Major Key Players In The Vendor Neutral Archive (VNA) Market:
- Johnson & Johnson Private Limited
- Merck & Co., Inc.
- Hoffmann-La Roche Ltd.
- Baxter
- Bayer AG
- Eli Lilly and Company
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Lupin
- Allergan
- AbbVie Inc.
- Abbott
- Bausch Health Companies Inc.
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- AstraZeneca
- Other Prominent Players
Market Segmentation:
The vendor-neutral archive (VNA) market is segmented based on deployment model, vendor type, imaging type, and end user. As per the deployment model, the market is categorized into on-premise VNA and cloud-based VNA. By vendor type, the market is segmented into independent software vendors (ISVs), PACS vendors, and infrastructure vendors. By imaging type, the market is segmented into radiology VNAs, cardiology VNAs, and pathology VNAs. By end user, the market is segmented into hospitals, diagnostic imaging centers, ambulatory care centers, research and academic institutes.
As Per The Deployment Model, The On-Premise Segment Is Accounted As A Major Contributor To The Vendor Neutral Archive (VNA) Market.
The on-premise vendor-neutral archive (VNA) market is expected to hold a major global market share in 2022. With on-premises delivery, clients may take advantage of customized integration with their current business systems. The data and servers are physically situated in the workplace, adding an added layer of security.
Hospital Segment To Witness Growth At A Rapid Rate.
Hospitals necessitate resilient and adaptable VNA solutions that can seamlessly merge with different departments and systems, guaranteeing streamlined access to and control of patient imaging data throughout the facility.
In The Region, The North American Vendor Neutral Archive (VNA) Market Holds A Significant Revenue Share.
The North American vendor-neutral archive (VNA) market is expected to record a large market share in revenue in the near future. It can be attributed to the rise in government efforts, better healthcare infrastructure, and increased spending on research and development. In addition, Asia Pacific is projected a rapid growth in the global Vendor neutral archive (VNA) Market because the government has invested more money into healthcare and is investing more in technology and new programs.
Recent Developments:
- In Sept 2021, Roche had implemented the Roche Digital Pathology Open Environment, a workflow application for pathologists that enabled software developers to effortlessly integrate their image analysis tools for tumor tissue with Roche's uPath enterprise software. The open environment facilitated the secure transmission and circulation of data, granting pathologists access to sophisticated algorithms developed by external entities in addition to Roche's suite of image analysis tools based on artificial intelligence.
- In Feb 2023, FUJIFILM Healthcare Americas Corporation, a prominent supplier of advanced imaging and informatics solutions, has announced that its Synapse VNA and Synapse Radiology PACS (in Latin America) have achieved the top ranking in the 2023 'Best in KLAS' report. This report, conducted by KLAS Research, acknowledges software and services companies that have demonstrated exceptional performance in assisting healthcare professionals in enhancing patient care.
Vendor Neutral Archive (VNA) Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 3.85 Bn |
|
Revenue Forecast In 2031 |
USD 5.81 Bn |
|
Growth Rate CAGR |
CAGR of 5.48% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Deployment Model, Vendor Type, Imaging Type, And End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
Johnson & Johnson Private Limited, Merck & Co., Inc., F.Hoffmann-La Roche Ltd., Baxter, Bayer AG, Eli Lilly and Company, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, Allergan, AbbVie Inc., Abbott, Bausch Health Companies Inc., Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, AstraZeneca and Other market players |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
